Rachel Rothschild
Pediatrics · Danbury, CTNPI 1538140850
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,186 and has fallen 65.1% since, to $415 in 2025. Among pediatrics clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$529
- Cranial Technologies, Inc$328
- Corium, LLC$271
- Merck$239
- Pfizer$217
- Ironshore Pharmaceuticals Inc.$179
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,481100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 10 | $529 |
| Cranial Technologies, Inc | 21 | $328 |
| Corium, LLC | 9 | $271 |
| Merck | 15 | $239 |
| Pfizer | 12 | $217 |
| Ironshore Pharmaceuticals Inc. | 11 | $179 |
| Tris Pharma Inc | 12 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $161 |
| Sanofi Pasteur Inc. | 6 | $159 |
| Kaleo, Inc. | 8 | $142 |
| Boehringer Ingelheim | 6 | $140 |
| Seqirus USA Inc | 6 | $133 |
| GSK | 6 | $110 |
| Verrica Pharmaceuticals Inc. | 5 | $80 |
| Exeltis, USA Inc. | 1 | $78 |
| AstraZeneca | 3 | $72 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Genentech USA, Inc. | 5 | $68 |
| Sobi, Inc | 3 | $47 |
| Neos Therapeutics, LP | 3 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Vertical Pharmaceuticals, LLC | 2 | $34 |
| Adlon Therapeutics L.p. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Meridian Bioscience Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,481 in reported general payments places this provider in the 95th percentile of 681 pediatrics providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $148 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 12 | $145 |
| Atorvastatin Calcium | 14 | $135 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Danbury
- Bruce CohenDanbury$5K
- Aaron SlaibyDanbury$3K
- Jamie AlonDanbury$3K
- Poonam BherwaniDanbury$2K
- Jose ArraianoDanbury$2K
- Alan MuneyDarien$369K
- Amanda ZuseHartford$45K
- Nicholas BennettHartford$37K
- William ZempskyHartford$35K
- Eugene ShapiroNew Haven$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.